The CDC's Advisory Committee on Immunization Practices is set to meet again today to recommend whether vaccinations with Johnson & Johnson's Covid-19 shot could resume in the U.S. The CDC and FDA urged a pause on the use of J&J's vaccine on April 13, after identifying serious but rare instances of blood clots in six women who received the shot.